Lineage Cell Therapeutics, Inc. (AMEX: LCTX) Q4 2022 Earnings Call Transcript March 9, 2023 Operator: Welcome to the Lineage Cell Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results